Skip to content
Home
Close Home
Open Home
Journal information
Editorial board
Operations manual
Editorial policies
Code of conduct for authors
Code of conduct for reviewers
Ahead of print
Read
Close Read
Open Read
Archive
TOC Alert
Current issue
Information
Close Information
Open Information
Editorial & Peer Review
Ethical policies
Funding
Complaints and appeals
Open access and licensing
Authors
Sponsorship
Contact
Publish
Close Publish
Open Publish
Instructions to authors
Online submission
Español
English
Home
Journal Information
Editorial Board
Operations Manual
Editorial Polices
Code of conduct for authors
Code of conduct for reviewers
Ahead of print
Read
Archive
Toc Alert
Current issue
Information
Editorial & Peer review
Ethical policies
Funding
Procedure for complaints and/or appeals
Open access & Licensing
Authors
Sponsors
Contact
Publish
Authors Instructions
Online submission
Home
Journal Information
Editorial Board
Operations Manual
Editorial Polices
Code of conduct for authors
Code of conduct for reviewers
Ahead of print
Read
Archive
Toc Alert
Current issue
Information
Editorial & Peer review
Ethical policies
Funding
Procedure for complaints and/or appeals
Open access & Licensing
Authors
Sponsors
Contact
Publish
Authors Instructions
Online submission
ES
EN
TOC Alert
Volume 1 – Number 1
2024
>
Volume 1 - Number 1
Prophylaxis in non-severe forms of hemophilia: experience of the HemoNorte working group
2024
>
Volume 1 - Number 1
Welcome
2024
>
Volume 1 - Number 1
Editorial
2024
>
Volume 1 - Number 1
Antiphospholipid syndrome: is there a preclinical period?
2024
>
Volume 1 - Number 1
Utility of phospholipid-sensitive and insensitive APTT pairs together with dRVVT in the diagnosis of lupus anticoagulant
2024
>
Volume 1 - Number 1
In vitro culture of megakaryocytes forming proplatelets from CD34+ cells obtained from peripheral blood
2024
>
Volume 1 - Number 1
Indirect comparison of two real-life studies in immune thrombocytopenia using artificial intelligence
2024
>
Volume 1 - Number 1
Galician-Asturian experience of avatrombopag use in immune thrombocytopenia